Keyphrases
Pediatric Rheumatology
100%
CARRA
100%
Evidence-based
100%
Rheumatic Diseases
64%
Translational Research
28%
Distributed Databases
14%
Clinical Research Participation
14%
Pathogenic Mechanism
14%
Biomarker Development
14%
Clinical Research
14%
Biomarker Discovery
14%
Disease Registry
14%
Sample Integrity
7%
Disease Metrics
7%
Local Awareness
7%
Protocolized Care
7%
Laboratory Network
7%
Catapult
7%
Infrastructure Provision
7%
I2b2
7%
Electronic Data Capture
7%
New Biomarkers
7%
Security Level
7%
Ontological Basis
7%
Informatics
7%
Systemic Lupus
7%
Performance Level
7%
Health Outcomes
7%
Expert Consultation
7%
Database Structure
7%
Participation in Research
7%
Grant Funding
7%
Translational Studies
7%
Infrastructure Investment
7%
Quality of Life
7%
Community Barriers
7%
Pediatric Oncology
7%
Advocacy Groups
7%
Research Laboratories
7%
Vasculitis Syndrome
7%
Clinic Visits
7%
Disease-related
7%
Systemic Juvenile Idiopathic Arthritis (sJIA)
7%
Patient Care
7%
Rare Diseases
7%
Rheumatology Research
7%
Advisory Board
7%
Biospecimens
7%
Clinical Trials
7%
Pediatric Cancer
7%
Number of children
7%
Scleroderma
7%
Full Participation
7%
Data Capture
7%
Pain Syndrome
7%
Healthcare Professionals
7%
Data Storage
7%
Research Participation
7%
Public-private Partnership
7%
Affected children
7%
HIPAA
7%
Arthritis
7%
Clinical Trials Network
7%
Comparative Effectiveness Research
7%
Family Caregiving
7%
Funding Mechanisms
7%
Health Advocacy
7%
Oncology Research
7%
Evidence-based Treatment
7%
Treatment Protocol
7%
Biorepository
7%
Evidence-based Protocol
7%
Informatics Infrastructure
7%
Children's Oncology Group
7%
Informatic Platforms
7%
Dermatomyositis
7%
Medicine and Dentistry
Pediatric Rheumatology
100%
Rheumatic Disease
100%
Clinical Research
83%
Diseases
66%
Translational Research
50%
Research Participation
50%
Pediatric Rheumatic Disease
50%
Biological Marker
33%
Biorepository
16%
Childhood Cancer
16%
Clinical Translational Research
16%
Oncology
16%
Vasculitis
16%
Pediatric Cancer
16%
Rare Disease
16%
Public-Private Partnership
16%
Volunteer
16%
Clinical Trial
16%
Quality of Life
16%
Lupus Vulgaris
16%
Health Outcomes
16%
Arthritis
16%
Family-Centered Care
16%
Scleroderma
16%
Awareness
16%
Dermatomyositis
16%
Juvenile Idiopathic Arthritis
16%
Health Care Personnel
16%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatic Disease
100%
Diseases
44%
Clinical Research
33%
Biological Marker
22%
Malignant Neoplasm
11%
Childhood Cancer
11%
Vasculitis
11%
Scleroderma
11%
Clinical Trial
11%
Juvenile Rheumatoid Arthritis
11%
Arthritis
11%
Lupus Vulgaris
11%
Rare Disease
11%
Dermatomyositis
11%